Latest Series A Funding Rounds
Companies raising their first major institutional growth round, from the product they sell to the investors backing their next stage.
- Rounds
- 883 All time
- Disclosed funding
- $34.2B 796 disclosed amounts
- Median round
- $20M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| AS Astral SystemsCompany profile Develops multi-state fusion technology for medical radioisotopes and commercial applications Develops multi-state fusion technology for medical radioisotopes and commercial applications | £23M | Series A | Industrial tech | United Kingdom | Investors | |
| HZ H3 ZoomCompany profile Builds AI-powered inspection and asset-intelligence software for the built environment Builds AI-powered inspection and asset-intelligence software for the built environment | $3.6M | Series A | Proptech | Singapore | Investors | |
| BP Bionyra PharmaCompany profile Bionyra Pharma develops biologic therapies for severe immunological and inflammatory diseases. Bionyra Pharma develops biologic therapies for severe immunological and inflammatory diseases. | $165M | Series A | Biotech | France | Investors | |
| S Manufactures commercial electric vehicles for middle mile logistics | $21M | Series A | Mobility | United Kingdom | Investors | |
| UA Upscale AICompany profile Provides open-standard AI networking infrastructure for ultra-low-latency training and inference Provides open-standard AI networking infrastructure for ultra-low-latency training and inference | $190M | Series A+Series A | Hardware | United States | Investors | |
| PA Prosper AICompany profile Automates the patient journey from scheduling and insurance to billing and collections Automates the patient journey from scheduling and insurance to billing and collections | $30M | Series A | Healthtech | United States | Investors | |
| GT Graph TherapeuticsCompany profile Develops precision medicines for inflammatory and immune-mediated diseases using AI-powered patient cell analysis Develops precision medicines for inflammatory and immune-mediated diseases using AI-powered patient cell analysis | $5M | Series A | Biotech | Austria | Investors | |
| SB Syntax BioCompany profile Develops cell therapies using proprietary Cellgorithm platform for regenerative medicine Develops cell therapies using proprietary Cellgorithm platform for regenerative medicine | $14.4M | Series A+Series A | Biotech | United States | Investors | |
| KT Kvasir TechnologiesCompany profile Converts lignin-based agricultural and forestry residues into maritime biofuels. Converts lignin-based agricultural and forestry residues into maritime biofuels. | €10M | Series A | Climate tech | Denmark | Investors | |
| CM Cuprum MetalsCompany profile Develops chemical leaching technology for copper extraction from ores and tailings Develops chemical leaching technology for copper extraction from ores and tailings | $19.4M | Series A | Climate tech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1Y Combinator (YC)
Clueso, Santé, Flai
52rounds0led - 2Andreessen Horowitz (a16z)
Eka Robotics, TypeSafe AI, Sharp Performance
29rounds9led - 3General Catalyst
Baba, Melius, Disha (formerly Curelink)
24rounds1led - 4Lightspeed
Warp Sciences, Zenzap, Avarra
21rounds4led - 5Alumni Ventures
Chariot Claims, RegCell, Inc., Lightfield
21rounds0led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.